MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Psychiatric manifestations in premanifest Huntington’s disease as early indicators of motor onset: a systematic review

    E. Pérez Rodríguez, R. Cundapí González, I. González López, K. Gálvez Deleón, S. Domínguez Castro, D. Velázquez Ruiz, M. Serrano Velázquez, O. Barrios Julian (Tapachula, Mexico)

    Objective: To identify and analyze psychiatric manifestations acting as early indicators in individuals carrying the HTT gene mutation during the premanifest stage, evaluating their prevalence…
  • 2026 International Congress

    Efficacy of Mechanoacoustic Vibration Therapy on Motor Function, Bone Density, and Sleep Architecture in Elderly Women with Restless Legs Syndrome

    E. -, R. Kumar (New Delhi, India)

    Objective: To evaluate the rehabilitative impact of targeted mechanoacoustic vibration therapy on mobility, bone mineral density (BMD), pain, and sleep quality in elderly women with…
  • 2026 International Congress

    Effects of Chronic IEM-1460 Treatment on Perineuronal Net–Parvalbumin Interneuron Association in L-DOPA-Induced Dyskinesia

    NT. Bilbay, EN. Kaptan, C. Cakir-Aktas, G. Yalcin-Cakmakli, B. Elibol, BC. Tel (Ankara, Turkey)

    Objective: To determine whether chronic IEM-1460 administration alters dyskinesia and perineuronal net (PNN)–parvalbumin interneuron (PV-IN) association in a 6-OHDA rat model of L-DOPA-induced dyskinesia (LID).…
  • 2026 International Congress

    Transcutaneous Auricular Vagus Nerve Stimulation as a Novel Therapy for Parkinson’s Disease: Meta-Analytic Evidence of Motor and Gait Effects

    K. Sarhan (Mansoura, Egypt)

    Objective: To evaluate the effects of transcutaneous auricular vagus nerve stimulation (taVNS) on motor function and gait in patients with Parkinson’s disease (PD). Background: taVNS…
  • 2026 International Congress

    Mechanisms of PLA2G6 Deficiency Impacting Mitochondria-associated membranes in Parkinson’s Disease

    JB. Liu, BS. Tang, JQ. Tan, JF. Guo (Changsha, China)

    Objective: This study aims to explore the functions of PLA2G6 protein at the endoplasmic reticulum-mitochondria interface, unveiling the potential mechanisms of PLA2G6-related Parkinson’s disease (PD)…
  • 2026 International Congress

    Blood glucose homeostasis is conserved in patients with mild to moderate Spinocerebellar Ataxia type 2

    R. Aguilera-Rodríguez, D. Almaguer-Gotay, A. álvarez-Sosa, M. Anidos-Machado, Y. Silva-Ricardo, D. Cuello-Almarales, A. Estupiñán-Rodríguez, L. Almaguer-Mederos (Holguín, Cuba)

    Objective: To explore novel molecular biomarker candidates for SCA2, based on the assessment of blood glucose homeostasis. Background: Spinocerebellar ataxia type 2 (SCA2) is a…
  • 2026 International Congress

    Ambulatory prognosis in spinocerebellar ataxia type 6: a single-center cohort study

    J. Nunomura (Aomori, Japan)

    Objective: To evaluate the ambulatory prognosis and fall-related events in patients with spinocerebellar ataxia type 6 (SCA6) in a real-world clinical setting. Background: SCA6 is…
  • 2026 International Congress

    The Lived Experience of Parkinson’s Disease in the Philippines: Challenges, Cultural Constructs, and Caregiving Impacts

    FM. Lawas, GS. Saranza, JH. Hernani (Cebu, Philippines)

    Objective: This study aims to explore the lived experiences of PD patients and their caregivers in Cebu Province, Philippines; identify psychosocial and healthcare-related challenges; assess…
  • 2026 International Congress

    Clinical Features and Trajectories Related to Entacapone Use in Parkinson’s Disease: insights from the French NS Park Cohort

    S. Gallo, P. Bastos, JE. Timmermann, M. Fabbri, B. Morlaes, O. Rascol (Toulouse, France)

    Objective: This study aimed to provide real-life entacapone use in French PD expert centers, focusing on temporal trends, therapeutic positioning, and treatment persistence. Background: Optimizing…
  • 2026 International Congress

    Genetic modifiers of the clinical phenotype in Spinocerebellar Ataxia type 2. 25 years of candidate genes studies and the forthcoming GWAS era

    L. Almaguer-Mederos (London, United Kingdom)

    Objective: To provide a critical review the state of the art on the search for modifier genes for disease severity of SCA2. Background: Spinocerebellar ataxia…
  • « Previous Page
  • 1
  • …
  • 201
  • 202
  • 203
  • 204
  • 205
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley